Piramal Pharma has reported results for third quarter ended December 31, 2022. (Q3FY23)
The company has reported net loss of Rs 2.42 crore for Q3FY23 as compared to net profit of Rs 111.76 crore for the corresponding quarter previous year. However, total income of the company increased by 1.66% to Rs 867.17 crore for the quarter under review as compared to Rs 853.00 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported net loss of Rs 90.18 crore for Q3FY23 as compared to net profit of Rs 163.37 crore for the same quarter in the previous year. However, total income of the company increased by 5.81% to Rs 1,798.51 crore for the quarter under review as compared to Rs 1,699.68 crore for the same quarter in the previous year.
